RNA-binding Proteins and Exoribonucleases Modulating MiRNA in Cancer: the Enemy Within

Overview

Journal Exp Mol Med

Specialties Biochemistry
Molecular Biology

Date 2024 Apr 30

PMID 38689093

Authors

Yoona Seo

Jiho Rhim

Jong Heon Kim

Affiliations

Soon will be listed here.

Abstract

Recent progress in the investigation of microRNA (miRNA) biogenesis and the miRNA processing machinery has revealed previously unknown roles of posttranscriptional regulation in gene expression. The molecular mechanistic interplay between miRNAs and their regulatory factors, RNA-binding proteins (RBPs) and exoribonucleases, has been revealed to play a critical role in tumorigenesis. Moreover, recent studies have shown that the proliferation of hepatocellular carcinoma (HCC)-causing hepatitis C virus (HCV) is also characterized by close crosstalk of a multitude of host RBPs and exoribonucleases with miR-122 and its RNA genome, suggesting the importance of the mechanistic interplay among these factors during the proliferation of HCV. This review primarily aims to comprehensively describe the well-established roles and discuss the recently discovered understanding of miRNA regulators, RBPs and exoribonucleases, in relation to various cancers and the proliferation of a representative cancer-causing RNA virus, HCV. These have also opened the door to the emerging potential for treating cancers as well as HCV infection by targeting miRNAs or their respective cellular modulators.

Citing Articles

Deciphering the roles of non-coding RNAs in liposarcoma development: Challenges and opportunities for translational therapeutic advances.

Chong Z, Ho W, Yeap S Noncoding RNA Res. 2024; 11:73-90.

PMID: 39736850 PMC: 11683247. DOI: 10.1016/j.ncrna.2024.11.005.

MicroRNAs and RNA-Binding Protein-Based Regulation of Bone Metastasis from Hepatobiliary Cancers and Potential Therapeutic Strategies.

Fagoonee S, Weiskirchen R Cells. 2024; 13(23).

PMID: 39682684 PMC: 11640337. DOI: 10.3390/cells13231935.

Identification of a novel survival and immune microenvironment related ceRNA regulatory network for hepatocellular carcinoma based on circHECTD1.

Lan S, Zhong G Heliyon. 2024; 10(13):e33763.

PMID: 39040406 PMC: 11261882. DOI: 10.1016/j.heliyon.2024.e33763.

References

Gebert L, MacRae I . Regulation of microRNA function in animals. Nat Rev Mol Cell Biol. 2018; 20(1):21-37. PMC: 6546304. DOI: 10.1038/s41580-018-0045-7. View

Rhim J, Baek W, Seo Y, Kim J . From Molecular Mechanisms to Therapeutics: Understanding MicroRNA-21 in Cancer. Cells. 2022; 11(18). PMC: 9497241. DOI: 10.3390/cells11182791. View

Ha M, Kim V . Regulation of microRNA biogenesis. Nat Rev Mol Cell Biol. 2014; 15(8):509-24. DOI: 10.1038/nrm3838. View

Croce C . Causes and consequences of microRNA dysregulation in cancer. Nat Rev Genet. 2009; 10(10):704-14. PMC: 3467096. DOI: 10.1038/nrg2634. View

Vojtechova Z, Tachezy R . The Role of miRNAs in Virus-Mediated Oncogenesis. Int J Mol Sci. 2018; 19(4). PMC: 5979478. DOI: 10.3390/ijms19041217. View

Jopling C . Targeting microRNA-122 to Treat Hepatitis C Virus Infection. Viruses. 2011; 2(7):1382-1393. PMC: 3185717. DOI: 10.3390/v2071382. View

Lu J, Getz G, Miska E, Alvarez-Saavedra E, Lamb J, Peck D . MicroRNA expression profiles classify human cancers. Nature. 2005; 435(7043):834-8. DOI: 10.1038/nature03702. View

Pereira B, Billaud M, Almeida R . RNA-Binding Proteins in Cancer: Old Players and New Actors. Trends Cancer. 2017; 3(7):506-528. DOI: 10.1016/j.trecan.2017.05.003. View

Mohibi S, Chen X, Zhang J . Cancer the'RBP'eutics-RNA-binding proteins as therapeutic targets for cancer. Pharmacol Ther. 2019; 203:107390. PMC: 6848768. DOI: 10.1016/j.pharmthera.2019.07.001. View

10.

Kim J, Hahm B, Kim Y, Choi M, Jang S . Protein-protein interaction among hnRNPs shuttling between nucleus and cytoplasm. J Mol Biol. 2000; 298(3):395-405. DOI: 10.1006/jmbi.2000.3687. View

11.

Geuens T, Bouhy D, Timmerman V . The hnRNP family: insights into their role in health and disease. Hum Genet. 2016; 135(8):851-67. PMC: 4947485. DOI: 10.1007/s00439-016-1683-5. View

12.

Guil S, Caceres J . The multifunctional RNA-binding protein hnRNP A1 is required for processing of miR-18a. Nat Struct Mol Biol. 2007; 14(7):591-6. DOI: 10.1038/nsmb1250. View

13.

Srikantan S, Tominaga K, Gorospe M . Functional interplay between RNA-binding protein HuR and microRNAs. Curr Protein Pept Sci. 2012; 13(4):372-9. PMC: 3535178. DOI: 10.2174/138920312801619394. View

14.

Seo Y, Kang Y, Ham Y, Kim M, Kim S, Yoon S . PLK1-ELAVL1/HuR-miR-122 signaling facilitates hepatitis C virus proliferation. Proc Natl Acad Sci U S A. 2022; 119(51):e2214911119. PMC: 9907111. DOI: 10.1073/pnas.2214911119. View

15.

Lo U, Pong R, Yang D, Gandee L, Hernandez E, Dang A . IFNγ-Induced IFIT5 Promotes Epithelial-to-Mesenchymal Transition in Prostate Cancer via miRNA Processing. Cancer Res. 2018; 79(6):1098-1112. DOI: 10.1158/0008-5472.CAN-18-2207. View

16.

Zhang H, Lu Y, Chen E, Li X, Lv B, Vikis H . XRN2 promotes EMT and metastasis through regulating maturation of miR-10a. Oncogene. 2017; 36(27):3925-3933. DOI: 10.1038/onc.2017.39. View

17.

Li Y, Masaki T, Yamane D, McGivern D, Lemon S . Competing and noncompeting activities of miR-122 and the 5' exonuclease Xrn1 in regulation of hepatitis C virus replication. Proc Natl Acad Sci U S A. 2012; 110(5):1881-6. PMC: 3562843. DOI: 10.1073/pnas.1213515110. View

18.

Sedano C, Sarnow P . Hepatitis C virus subverts liver-specific miR-122 to protect the viral genome from exoribonuclease Xrn2. Cell Host Microbe. 2014; 16(2):257-264. PMC: 4227615. DOI: 10.1016/j.chom.2014.07.006. View

19.

Yin J, Seo Y, Rhim J, Jin X, Kim T, Kim S . Cross-talk between PARN and EGFR-STAT3 Signaling Facilitates Self-Renewal and Proliferation of Glioblastoma Stem Cells. Cancer Res. 2023; 83(22):3693-3709. DOI: 10.1158/0008-5472.CAN-22-3965. View

20.

Lee K, Seo Y, Im J, Rhim J, Baek W, Kim S . Molecular Signature of Extracellular Vesicular Small Non-Coding RNAs Derived from Cerebrospinal Fluid of Leptomeningeal Metastasis Patients: Functional Implication of miR-21 and Other Small RNAs in Cancer Malignancy. Cancers (Basel). 2021; 13(2). PMC: 7828086. DOI: 10.3390/cancers13020209. View